Revisitation of the clinical indications for the transfusion of platelet concentrates (Q34434805)

2 August 2017

Revisitation of the clinical indications for the transfusion of platelet concentrates (English)

1 reference

2 August 2017

1 reference

Rebulla P

1

1 reference

2 August 2017

1 September 2001

1 reference

Reviews in Clinical and Experimental Hematology

2 August 2017

1 reference

2 August 2017

5

1 reference

2 August 2017

288-310; discussion 311-2

1 reference

2 August 2017

3

1 reference

Use of platelets and other transfusion products in patients with malignancy

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The rational use of platelet transfusions in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Pharmacological therapies to minimise platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Unexpected bleeding disorders: Algorithm for approach to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Delayed alloimmunisation by random single donor platelet transfusions. A randomised study to compare single donor and multiple donor platelet transfusions in cancer patients with severe thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Considerations in the selection of a platelet component: apheresis versus whole blood-derived

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Single donor platelets: can we afford to use them? Can we afford not to use them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Role of acetate during platelet storage in a synthetic medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Additive solutions for the storage of platelets for transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Human platelets frozen with glycerol in liquid nitrogen: biological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Cryopreservation of platelets: an in-vitro comparison of four methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Frozen autologous platelet transfusion for patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Leukocyte Reduction in Blood Component Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

LAV/HTLV-III plays a dominant role in the etiology of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Febrile reactions after platelet transfusion: the effect of single versus multiple donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Transfusion-associated graft-versus-host disease in an immunocompetent patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Storage of apheresis platelets after gamma radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

In vitro assessment of platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The Prophylactic Treatment of Thrombocytopenic Leukemic Patients with Platelets: a Double Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Indications for platelet transfusion in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The quantitative relation between platelet count and hemorrhage in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Lowering the prophylactic platelet transfusion threshold: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Automated CD61 immunoplatelet analysis of thrombocytopenic samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Thrombocytopenia and gastrointestinal hemorrhage in the cancer patient: prevalence of unmasked lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The significance of thrombocytopenia in the development of postoperative intracranial hematoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Complications of fiberoptic bronchoscopy in thrombocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Platelet transfusion therapy in newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Management of acquired coagulation disorders in emergency and intensive-care medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

A practical approach to the diagnosis and management of thrombocytopenia associated with glycoprotein IIb/IIIa receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

The management of abnormalities of hemostasis in acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Disseminated intravascular coagulation: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Management of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Trigger factors for prophylactic platelet transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Monitoring for underutilization of RBC components and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-0734.2001.00042.X

10.1046/J.1468-0734.2001.00042.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11703819